ScreenerHero

BLLN BillionToOne, Inc. - Class A common stock

NAS · US · Healthcare · Diagnostics & Research · billiontoone.com
105.54USD-0.34%Mkt Cap: 5.00B $P/E: 149.15

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the sing…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc. - Common Stock
$59.15BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
ILMN
Illumina, Inc. - Common Stock
$41.23BUSDP/E 50.8
IDXX
IDEXX Laboratories, Inc. - Common Stock
$40.89BUSDP/E 36.4
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
GH
Guardant Health, Inc. - Common Stock
$23.86BUSD
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc. - Common Stock
$16.73BUSDP/E 35.2
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON plc - Ordinary Shares
$12.50BUSDP/E 249.3
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap5.00B USD
Enterprise Value4.59B USD
Revenue (TTM)397.41M USD
Gross Profit208.46M USD
Net Income (TTM)7.45M USD
Revenue/Share11.76 USD
Last Price105.54 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees713
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)149.15
P/E (Forward)71.31
PEG—
EV/EBITDA91.41
EV/Revenue11.56
P/S12.57
P/B9.24
EPS (TTM)0.63
EPS (Forward)1.49
52W Range
61.9649% of range150.44
52W High150.44 USD
52W Low61.96 USD
Profitability
Gross Margin68.32%
Oper. Margin5.03%
EBITDA Margin12.64%
Profit Margin2.44%
ROE1.55%
ROA1.18%
Growth
Revenue Growth64.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF24.59M USD
CapEx (TTM)8.92M USD
FCF Margin3.03%
FCF Yield0.24%
Net Debt-404.71M USD
Net Debt/EBITDA-8.06
Balance Sheet
Debt/Equity0.23
Current Ratio11.69
Quick Ratio11.19
Book Value/Sh11.46 USD
Cash/Share11.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)129.00 USD
Upside (mean)+22.2%
Target Range110.00 USD – 145.00 USD
110.00+22.2% to mean145.00
# Analysts7
Ownership
Shares Out.42.64M
Float28.82M
Insiders28.35%
Institutions45.45%
Short Interest
Short Ratio4.7d
Short % Float10.04%
Short % Out.5.56%
Shares Short2.63M
Short (prev mo.)1.95M
Technical
SMA 50107.58 (-1.9%)
SMA 20095.19 (+10.9%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)624.59K
Avg Vol (10d)621.38K
Technical Indicators
RSI (14)47.6
MACD2.3455
MACD Signal2.6522
MACD Hist.-0.3067
BB Upper125.46 USD
BB Middle108.03 USD
BB Lower90.59 USD
BB Width32.28%
ATR (14)6.841 USD
Vol Ratio (20d)0.62x